Mitchell D Schnall Selected Research

Biomarkers (Surrogate Marker)

12/2020	What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
1/2016	Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
5/2015	Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell D Schnall Research Topics

Disease

28	Neoplasms (Cancer) 12/2020 - 03/2002
14	Breast Neoplasms (Breast Cancer) 06/2018 - 03/2003
3	Glioma (Gliomas) 01/2020 - 01/2017
2	Multiple Sclerosis 01/2022 - 09/2019
2	Pathologic Complete Response 06/2018 - 04/2016
2	Carcinoma (Carcinomatosis) 01/2017 - 12/2002
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 01/2006
2	Fibroadenoma 07/2014 - 07/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2008 - 01/2007
2	Carcinogenesis 01/2007 - 12/2002
2	Prostatic Neoplasms (Prostate Cancer) 06/2004 - 01/2003
1	Stable Angina 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Death (Near-Death Experience) 12/2020
1	Myocardial Infarction 12/2020
1	Residual Neoplasm 04/2016
1	Lymphoma (Lymphomas) 01/2016
1	Fibrosis (Cirrhosis) 08/2015
1	Necrosis 08/2015
1	Triple Negative Breast Neoplasms 07/2014
1	Carcinoma in Situ 01/2007
1	Lymphadenopathy 04/2004
1	Margins of Excision 01/2003
1	Cysts 03/2002

Drug/Important Bio-Agent (IBA)

5	GadoliniumIBA 01/2022 - 05/2004
5	Contrast MediaIBA 01/2017 - 03/2003
5	Hemoglobins (Hemoglobin)IBA 05/2015 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2015
2	Biological ProductsIBA 01/2020 - 05/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 01/2016
2	Sweetening Agents (Sweeteners)IBA 01/2019 - 01/2017
2	Protons (Proton)IBA 01/2019 - 01/2016
2	Hormones (Hormone)IBA 04/2016 - 06/2004
2	ErbB Receptors (EGF Receptor)IBA 04/2016 - 07/2014
1	omega-Chloroacetophenone (Mace)IBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	Hydroxyl RadicalIBA 01/2019
1	maltitolIBA 01/2019
1	Sugar AlcoholsIBA 01/2019
1	SolutionsIBA 01/2017
1	trichlorosucrose (sucralose)IBA 01/2017
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2016
1	A 19IBA 08/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Complement System Proteins (Complement)IBA 05/2015
1	Estrogen ReceptorsIBA 07/2014
1	taxaneIBA 06/2012
1	AnthracyclinesIBA 06/2012
1	N 30IBA 12/2008
1	Sorafenib (BAY 43-9006)FDA Link 04/2008
1	Angiogenesis InhibitorsIBA 04/2008
1	Pharmaceutical PreparationsIBA 01/2007
1	Tumor Biomarkers (Tumor Markers)IBA 08/2006
1	CytokinesIBA 08/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2004
1	P-2 (P 2)IBA 05/2004
1	AndrogensIBA 01/2003
1	Doxycycline (Periostat)FDA LinkGeneric 12/2002
1	Tetracycline (Achromycin)FDA LinkGeneric 12/2002
1	ElementsIBA 03/2002
1	Vitamin E FDA LinkGeneric 03/2002

Therapy/Procedure

7	Therapeutics 12/2020 - 01/2003
6	Neoadjuvant Therapy 06/2018 - 06/2012
3	Segmental Mastectomy (Lumpectomy) 01/2017 - 02/2004
3	Radiotherapy 01/2017 - 01/2003
2	Aftercare (After-Treatment) 12/2014 - 04/2004
2	Prophylactic Mastectomy 10/2014 - 03/2003
1	Mastectomy (Mammectomy) 01/2006
1	Prostatectomy (Retropubic Prostatectomy) 01/2003